105 related articles for article (PubMed ID: 15494771)
41. [Sudden death. Implantable defibrillators. Value of the technology and economic impact].
Jazra C
J Med Liban; 1999; 47(5):301-3. PubMed ID: 10887533
[No Abstract] [Full Text] [Related]
42. Cost-effectiveness in a flat world--can ICDs help the United States get rhythm?
Goldman L
N Engl J Med; 2005 Oct; 353(14):1513-5. PubMed ID: 16207856
[No Abstract] [Full Text] [Related]
43. The price of life.
Malik P
Can J Cardiol; 2002 Oct; 18(10):1052-3. PubMed ID: 12420039
[No Abstract] [Full Text] [Related]
44. [Implantable defibrillators and prevention of sudden death: clinical and economic implications in the light of the MADIT II study].
Boriani G; Biffi M; Martignani C; Branzi A
Monaldi Arch Chest Dis; 2002 Sep; 58(2):145-50. PubMed ID: 12418430
[TBL] [Abstract][Full Text] [Related]
45. [Roaming through methodology. V. The prevention paradox: few with a high risk versus many with a moderate risk].
Gunning-Schepers LJ
Ned Tijdschr Geneeskd; 1998 Aug; 142(33):1870-3. PubMed ID: 9856169
[TBL] [Abstract][Full Text] [Related]
46. The impact of implantable cardioverter defibrillator therapy on health care systems.
Saksena S
Am Heart J; 1994 Apr; 127(4 Pt 2):1193-200. PubMed ID: 8160600
[TBL] [Abstract][Full Text] [Related]
47. Hard times for hospital administrators. The problem of resource allocation.
Komesaroff P
Med J Aust; 1994 Apr; 160(8):468-71. PubMed ID: 8170420
[No Abstract] [Full Text] [Related]
48. [Implantable defibrillators. Good cost-effectiveness or supplementary expense to our hospitals?].
Lévy S; Aliot E; Clémenty J; Kacet S; Coumel P
Arch Mal Coeur Vaiss; 1999 Mar; 92(3):289-91. PubMed ID: 10221139
[No Abstract] [Full Text] [Related]
49. Cost-effectiveness of ICDs.
Anderson KP
N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16407520
[No Abstract] [Full Text] [Related]
50. A method for the early health technology assessment of novel biomarker measurement in primary prevention programs.
Postmus D; de Graaf G; Hillege HL; Steyerberg EW; Buskens E
Stat Med; 2012 Oct; 31(23):2733-44. PubMed ID: 22806952
[TBL] [Abstract][Full Text] [Related]
51. "We'll leave the light on.".
Cannavo MJ
Radiol Manage; 2002; 24(6):46-8. PubMed ID: 12546019
[No Abstract] [Full Text] [Related]
52. Technology: a growing cost in knee implant surgeries.
Mendenhall S
Healthc Financ Manage; 1989 Apr; 43(4):46, 48-50. PubMed ID: 10312914
[TBL] [Abstract][Full Text] [Related]
53. Life-cycle management: a long-term challenge.
Newman C
Med Device Technol; 2003 Apr; 14(3):32-3. PubMed ID: 12789698
[TBL] [Abstract][Full Text] [Related]
54. Getting a return on investment from spending capital dollars on new beds.
Hardy PA
J Healthc Manag; 2004; 49(3):199-205. PubMed ID: 15190861
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of medical methods--can we rely on cost-benefit-analysis?].
Kristiansen IS; Stavem K; Linnestad K; Pedersen KM
Tidsskr Nor Laegeforen; 2003 Mar; 123(5):657-60. PubMed ID: 12683199
[No Abstract] [Full Text] [Related]
56. Technology assessment for the anesthesiologist.
Abenstein JP
Anesthesiol Clin; 2006 Dec; 24(4):677-96. PubMed ID: 17342958
[TBL] [Abstract][Full Text] [Related]
57. Implantable defibrillator malfunctions should not be overlooked.
Hogle WP
Clin J Oncol Nurs; 2002; 6(5):252. PubMed ID: 12240481
[No Abstract] [Full Text] [Related]
58. Will that defibrillator really do the job? A recent report that 1 in 5 implanted defibrillators may not be needed raises questions about the medical evidence.
Kirkner RM
Manag Care; 2011 Jul; 20(7):39-41. PubMed ID: 21848198
[No Abstract] [Full Text] [Related]
59. [Implantable automatic defibrillator: the French delay].
Manus JM
Rev Infirm; 2003 Mar; (89):36. PubMed ID: 12728693
[No Abstract] [Full Text] [Related]
60. Response to xenograft technology: a new frontier in medicine. Xenograft technology: proceed with caution.
Glass E
Pediatr Nurs; 2000; 26(5):513-5. PubMed ID: 12026342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
